We are live on
!
Find out more
CAM
Close Asset Management Portfolio holdings
AUM
$3.69B
1-Year Est. Return
21.62%
This Fund
S&P 500
This Quarter
Est. Return
+12.14%
1 Year Est. Return
+21.62%
3 Year Est. Return
+85.9%
5 Year Est. Return
+91.67%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
+$212M
(+11%)
Cap. Flow
-$2.35M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
76.23%
Holding
237
New
10
Increased
54
Reduced
39
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$7.7M |
| 2 |
Air Products & Chemicals
APD
|
+$7.2M |
| 3 |
Applied Materials
AMAT
|
+$6.9M |
| 4 |
CERN
Cerner Corp
CERN
|
+$5.94M |
| 5 |
eBay
EBAY
|
+$4.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$15.8M |
| 2 |
Ingredion
INGR
|
+$10.1M |
| 3 |
Sony
SONY
|
+$5.93M |
| 4 |
TJX Companies
TJX
|
+$3.87M |
| 5 |
Ecolab
ECL
|
+$3.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.9% |
| 2 | Communication Services | 17.63% |
| 3 | Consumer Discretionary | 11.8% |
| 4 | Materials | 6.52% |
| 5 | Financials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Takeda Pharmaceutical
TAK
$56.7B
| – | – |
-441
| Closed | -$8K |
|
|
227
TJX Companies
TJX
$179B
| – | – |
-58,473
| Closed | -$3.87M |
|
228
TSMC
TSM
$1.94T
| – | – |
-6,029
| Closed | -$713K |
|
|
IRD
229
Opus Genetics
IRD
$287M
| $0 | ﹤0.01% |
20
| – | – |
|
|
SPWR
230
DELISTED
SunPower Corporation Common Stock
SPWR
| – | – |
-1,200
| Closed | -$40K |
|
|
FTCH
231
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| – | – |
-300
| Closed | -$16K |
|
|
MAXR
232
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $0 | ﹤0.01% |
5
| – | – |
|
|
LORL
233
DELISTED
Loral Space and Communications, Inc.
LORL
| $0 | ﹤0.01% |
3
| – | – |
|
|
CMD
234
DELISTED
Cantel Medical Corporation
CMD
| – | – |
-1,384
| Closed | -$110K |
|
|
GWPH
235
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-1,152
| Closed | -$250K |
|
|
BMY.RT
236
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-200
| Closed | – |
|
|
SBNY
237
DELISTED
Signature Bank
SBNY
| – | – |
-1
| Closed | – |
|
Similar funds
BB
EPIM
CI
TGA
SLG
OCBCO
HIM
MTIM
Close Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Close Asset Management held 237 positions worth $2.09B, up 11% from $1.88B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Close Asset Management's Q2 2021 filing shows 10 new, 54 increased, 39 reduced and 30 closed positions. Its largest new stake was ChargePoint: 2,530 shares worth $1.76M. The largest sale was Starbucks, an estimated $15.8M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Close Asset Management's largest Q2 2021 buy was ChargePoint: 2,530 shares worth $1.76M.
- Close Asset Management added most to Microsoft in Q2 2021, an estimated $7.7M increase.
- Close Asset Management's biggest Q2 2021 reduction was Ecolab, cutting an estimated $3.77M.
- Close Asset Management fully exited Starbucks in Q2 2021, selling an estimated $15.8M.
- Close Asset Management's ten largest holdings make up 76% of its $2.09B portfolio in Q2 2021.
- Close Asset Management opened 10 new positions and closed 30 in Q2 2021.
- Close Asset Management's portfolio value rose 11% quarter-over-quarter to $2.09B.
Based on Close Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.